Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion
Fangyang Huang, Jialiang Zhang, Hao Zhou, Tianyi Qu, Yan Wang, Kexin Jiang, Yutong Liu, Yuanning Xu, Mao Chen, Li Chen
Fangyang Huang, Jialiang Zhang, Hao Zhou, Tianyi Qu, Yan Wang, Kexin Jiang, Yutong Liu, Yuanning Xu, Mao Chen, Li Chen
View: Text | PDF
Research Article Cardiology Immunology

B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion

  • Text
  • PDF
Abstract

A robust, sterile inflammation underlies myocardial ischemia and reperfusion injury (MIRI). Several subsets of B cells possess the immunoregulatory capacity that limits tissue damage, yet the role of B cells in MIRI remains elusive. Here, we sought to elucidate the contribution of B cells to MIRI by transient ligation of the left anterior descending coronary artery in B cell–depleted or –deficient mice. Following ischemia and reperfusion (I/R), regulatory B cells are rapidly recruited to the heart. B cell–depleted or –deficient mice exhibited exacerbated tissue damage, adverse cardiac remodeling, and an augmented inflammatory response after I/R. Rescue and chimeric experiments indicated that the cardioprotective effect of B cells was not solely dependent on IL-10. Coculture experiments demonstrated that B cells induced neutrophil apoptosis through contact-dependent interactions, subsequently promoting reparative macrophage polarization by facilitating the phagocytosis of neutrophils by macrophages. The in vivo cardioprotective effect of B cells was undetectable in the absence of neutrophils after I/R. Mechanistically, ligand-receptor imputation identified FCER2A as a potential mediator of interactions between B cells and neutrophils. Blocking FCER2A on B cells resulted in a reduction in the percentage of apoptotic neutrophils, contributing to the deterioration of cardiac remodeling. Our findings unveil a potential cardioprotective role of B cells in MIRI through mechanisms involving FCER2A, neutrophils, and macrophages.

Authors

Fangyang Huang, Jialiang Zhang, Hao Zhou, Tianyi Qu, Yan Wang, Kexin Jiang, Yutong Liu, Yuanning Xu, Mao Chen, Li Chen

×

Figure 11

Exacerbation of MIRI by in vivo FCER2A blockade.

Options: View larger image (or click on image) Download as PowerPoint
Exacerbation of MIRI by in vivo FCER2A blockade.
Mice were injected with...
Mice were injected with anti-FCER2A antibody (150 μg per mouse, i.p.) or isotype immediately after I/R. (A) Representative M-mode echocardiography images of each group 14 days after I/R. (B) Measurements of cardiac function and size in each group 14 days after I/R. (C) Representative Masson’s trichrome staining of heart slices and quantification of infarct size after myocardial I/R in each group. Scale bars: 1000 μm. The infarct size was determined by calculating the ratio of the collagen area to the left ventricular area. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01 by unpaired t test. αFCER2A, anti-FCER2A antibody; I/R, ischemia and reperfusion; LVIDd, left ventricular diastolic dimension; LVIDs, left ventricular systolic dimension; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; I/R, ischemia and reperfusion.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts